Analyst Calls: AGN, AOL, DELL, KMB, MXB, RISK, SNDA, T ...


Analyst Upgrades

  • Keefe Bruyette upgraded MSCI Inc. (MXB) to outperform from market perform on valuation following Monday's sell-off as it views the acquisition of RiskMetrics (RISK) favorably. The firm has a $36 price target on shares. UBS also upgraded MSCI, to buy from neutral, and raised its target to $40 from $34, citing the recent pullback in shares and the accretive acquisition of RiskMetrics.
  • Deutsche Bank upgraded Suncor (SU) to hold from sell on valuation and raised its price target on shares to $28 from $20. The firm continues to prefer Canadian Natural (CNQ) to Suncor, however, and raised its target on shares to $80 from $78.
  • JMP Securities upgraded Grubb & Ellis (GBE) to outperform from market perform based on the improved operating environment and balance sheet, and valuation, among other reasons.
  • Dell (DELL) was upgraded to buy from neutral at UBS.
  • FEMSA (FMX) was upgraded to overweight from neutral at HSBC.
  • Westar Energy (WR) was upgraded to outperform from market perform at Wells Fargo.

Analyst Downgrades

  • Roth Capital downgraded Shanda Interactive (SNDA) to hold from buy to reflect limited earnings visibility from Shanda Games (GAME). The firm lowered its target for Shanda Interactive shares to $48 from $65.
  • JMP Securities downgraded RiskMetrics (RISK) to market perform from outperform following the announcement it will be acquired by MSCI (MXB). Credit Suisse also downgraded RiskMetrics, to neutral from outperform.
  • RBC Capital downgraded OSI Pharmaceuticals (OSIP) to sector perform from outperform on valuation, as it sees limited upside from current levels with the stock already pricing in an increased acquisition bid. The firm raised its target for shares to $56 from $37.
  • AT&T (T) was downgraded to neutral from overweight at HSBC.
  • Deutsche Telekom (DT) was downgraded to equal weight from overweight at Barclays.
  • Kimberly Clark (KMB) was downgraded to sell from neutral at Goldman.

Analyst Initiations

  • Calyon started Allergan (AGN) with an outperform rating and $66 target.
  • Jefferies initiated Aol (AOL) with a hold rating and $27 target.
  • Health Care REIT (HCN) was assumed with a neutral rating and $43 target at Goldman.
  • HCP Inc. (HCP) coverage was assumed with a neutral rating and $30 target at Credit Suisse.
  • Exco Resources (XCO) was initiated with an overweight rating and $29 target at Barclays.
  • Portfolio Recovery (PRAA) coverage was resumed with an outperform rating at William Blair.
Symbol Lookup
IndexesChangePrice
DJIA-111.8612,778.60
NASDAQ-17.672,909.56
S&P 500-9.591,342.36

Last updated: February 10, 2012: 01:31 PM

Hot Stocks

General Electric

18.905-0.225(-1.18)

Alcoa

10.31-0.33(-3.10)

Apple Inc

494.56+1.39(+0.28)

Google Inc 'A'

607.09-4.37(-0.71)

Bank of America

8.095-0.085(-1.04)

Wal-Mart Stores

61.50-0.46(-0.74)

Exxon Mobil Corp

83.73-1.15(-1.35)

Ford

12.385-0.305(-2.40)

Citigroup

32.93-0.73(-2.17)

IBM

191.68-1.45(-0.75)

Yahoo

16.21+0.21(+1.31)

Starbucks

48.80-0.40(-0.81)

Microsoft

30.55-0.22(-0.72)

Home Depot

45.225-0.045(-0.10)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328898704973 ms.